COMP <GO>
CR vs BRK-A // 10Y YIELD & FRED MACRO BETA
Crane Company (NYSE) VS. Berkshire Hathaway Inc. (Class A) (NYSE) • 15-METRIC TALLY: CR 5
— BRK-A 7
▲ 10Y YIELD & FRED MACRO BETA LEADER: BRK-A
LAST: $205.81 (+3.72%) • MKT CAP: $11.90B
macro-sensitivity
1.09
LAST: $817,500.00 (+0.68%) • MKT CAP: $1.20T
macro-sensitivity
1.13
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CR VS. BRK-A)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CR | BRK-A | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 42.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 12.40% | 11.47% | +0.93 | CR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.5x | 9.7x | +14.82 | BRK-A | /valuation <GO> |
| Free Cash Flow Yield | 2.64% | 2.09% | +0.55 | CR | /fcf-yield <GO> |
| Operating Margin | 18.40% | 27.80% | -9.40 | BRK-A | /operating-margins <GO> |
| Net Profit Margin | 15.90% | 22.30% | -6.40 | BRK-A | /net-margins <GO> |
| Revenue Growth (YoY) | 8.20% | 3.93% | +4.27 | CR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.44% | 0.00% | +0.44 | CR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.16 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 4/9 | +5.00 | CR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.1 | 68.1 | -14.00 | BRK-A | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.09 | 1.13 | -0.04 | BRK-A | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.1x | 24.3x | +5.76 | BRK-A | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.90B | $1.20T | -$1.19T | BRK-A | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CR REV | BRK-A REV | CR GROSS % | BRK-A GROSS % | CR FCF | BRK-A FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.31B | $247.24B | 42.2% | — | — | $25.04B |
| FY 2024 | $2.13B | $249.71B | 40.7% | — | — | $11.62B |
| FY 2023 | $1.86B | $254.91B | — | — | — | $37.73B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CR // BETA 1.09
BRK-A // BETA 1.13